Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Stacey Tinianov and I discuss the language of cancer, respecting an individual's context, and empowering patients to be engaged in their care.
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.
Why do patients hold back about serious side effects? Often, the reason is fear, writes cancer survivor and patient advocate Dr. Mary Dominiecki.
By holding its scientific program on time, ASCO and the entire oncology community make a pledge that we will continue advancing and offering the best care for our patients worldwide. 
As companies and organizations hurry to prepare timely resources for physicians during COVID-19, Drs. Deborah Mukherji, Sana Al-Sukhun, Shaheenah Dawood, Iman Abou Dalle, and Sally Temraz have noted an unwelcome return of the "manel": expert panels composed of only men.
In adversity, there is opportunity: despite the cancellation of an incredible professional opportunity due to COVID-19, Dr. Khalid El Bairi is focusing on how he can have a positive impact as an early-career oncologist in Morocco.
We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer whom we serve.
As New York City moves toward its new normal, Dr. Astha Thakkar considers the lessons learned over the past 7 weeks of crisis and rapid change due to COVID-19.
Dr. Sumanta K. Pal recounts the professional and personal rewards of investing in trainees from abroad as his mentees and friends Dr. Cristiane Bergerot and Dr. Paulo Bergerot return to their home country of Brazil.
The number of new and old agents being suggested as COVID-19 therapies seems to be expanding exponentially. Dr. Donald L. Trump, Dr. Courtney W. Houchen, and Dr. Milton L. Brown highlight current investigations.
At a time when every physician is needed, U.S. visa restrictions on international medical graduates are making it impossible for them to do the most good, writes Dr. Sreekanth Donepudi. 
Dr. Douglas Flora learned from his own cancer experience that when there's no wind, we must row.
Dr. Jii Bum Lee and Dr. Sun Young Rha describe the safety protocols that are enabling cancer providers in South Korea to reduce the risk of COVID-19 exposure for their patients.
In the close quarters imposed by COVID-19, a conflicted couple began to relate to each other differently.
Jennifer Merschdorf of Young Survival Coalition and I discuss how she brings her business experience to the social-profit space and the value of partnerships in advocacy.
Dr. Jason Westin explains the science behind the transformative CAR T-cell therapy, and the financial concern it presents to our health care system and our patients.
Oncology professionals must take a systematic approach to the compound challenge they face: providing timely, safe, and appropriate care to their patients while taking care of themselves and their staff. 
A healing touch, a warm embrace—these are luxuries of patient care for another time, the joys of clinical practice that must be suspended, write Dr. Varun Kumar Chowdhry and Dr. Shilpa Mukunda Chowdhry.

Pages


Advertisement